Solazyme Reports Second Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Cowen Cuts Price Target on Solazyme (SZYM) Following Earnings Results
July 31, 2015 7:56 AM EDTCowen maintained a Market Perform rating on Solazyme (NASDAQ: SZYM), and cut the price target to $3.25 (from $4.00), following its earnings results. Solazyme reported $11.7mn in revenue for the quarter, missing consensus estimates of and $14.3mn. Adjusted EPS was ($0.40) versus consensus estimate of ($0.37).
Analyst... More
Solazyme (SZYM) Misses Q2 EPS by 4c
July 30, 2015 4:22 PM EDTSolazyme (NASDAQ: SZYM) reported Q2 EPS of ($0.40), $0.04 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $11.7 million versus the consensus estimate of $14.34 million.
We are making good progress against our core deliverables, the commercialization of high value products across... More
